Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

Gut Liver. 2017 Jan 15;11(1):3-4. doi: 10.5009/gnl16574.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Drug Monitoring*
  • Humans
  • Inflammatory Bowel Diseases
  • Infliximab
  • Tumor Necrosis Factor-alpha*

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab